TCM
Traynor Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.8M | Buy |
29,479
+1,623
| +6% | +$868K | 1.12% | 19 |
|
|
2025
Q1 | $17.7M | Buy |
27,856
+3,066
| +12% | +$1.94M | 1.49% | 11 |
|
|
2024
Q4 | $17.7M | Buy |
24,790
+2,400
| +11% | +$1.71M | 1.18% | 13 |
|
|
2024
Q3 | $23.5M | Buy |
22,390
+2,071
| +10% | +$2.18M | 1.41% | 9 |
|
|
2024
Q2 | $21.4M | Buy |
20,319
+573
| +3% | +$602K | 1.6% | 10 |
|
|
2024
Q1 | $19M | Buy |
19,746
+878
| +5% | +$845K | 1.65% | 9 |
|
|
2023
Q4 | $16.6M | Buy |
18,868
+667
| +4% | +$586K | 1.7% | 8 |
|
|
2023
Q3 | $15M | Buy |
18,201
+684
| +4% | +$563K | 1.88% | 7 |
|
|
2023
Q2 | $12.6M | Buy |
17,517
+610
| +4% | +$438K | 1.54% | 10 |
|
|
2023
Q1 | $13.9M | Buy |
16,907
+1,153
| +7% | +$947K | 2.01% | 8 |
|
|
2022
Q4 | $11.4M | Sell |
15,754
-2,409
| -13% | -$1.74M | 1.6% | 8 |
|
|
2022
Q3 | $12.5M | Buy |
18,163
+176
| +1% | +$121K | 2.23% | 8 |
|
|
2022
Q2 | $10.6M | Buy |
17,987
+43
| +0.2% | +$25.4K | 1.84% | 10 |
|
|
2022
Q1 | $12.5M | Buy |
17,944
+671
| +4% | +$469K | 1.63% | 11 |
|
|
2021
Q4 | $10.9M | Buy |
17,273
+2,287
| +15% | +$1.44M | 1.29% | 17 |
|
|
2021
Q3 | $9.07M | Buy |
14,986
+1,396
| +10% | +$845K | 1.24% | 17 |
|
|
2021
Q2 | $7.93M | Buy |
13,590
+947
| +7% | +$553K | 1.11% | 21 |
|
|
2021
Q1 | $5.98M | Buy |
12,643
+482
| +4% | +$228K | 0.99% | 24 |
|
|
2020
Q4 | $5.88M | Buy |
12,161
+1,949
| +19% | +$942K | 1.04% | 23 |
|
|
2020
Q3 | $5.92M | Buy |
10,212
+685
| +7% | +$397K | 1.36% | 13 |
|
|
2020
Q2 | $5.94M | Buy |
9,527
+3,320
| +53% | +$2.07M | 1.43% | 13 |
|
|
2020
Q1 | $3.03M | Buy |
6,207
+3,273
| +112% | +$1.6M | 1.08% | 21 |
|
|
2019
Q4 | $1.1M | Sell |
2,934
-14
| -0.5% | -$5.26K | 0.29% | 72 |
|
|
2019
Q3 | $817K | Sell |
2,948
-103
| -3% | -$28.5K | 0.26% | 73 |
|
|
2019
Q2 | $966K | Buy |
3,051
+62
| +2% | +$19.6K | 0.31% | 65 |
|
|
2019
Q1 | $1.23M | Buy |
2,989
+1,376
| +85% | +$565K | 0.41% | 49 |
|
|
2018
Q4 | $602K | Buy |
1,613
+9
| +0.6% | +$3.36K | 0.25% | 68 |
|
|
2018
Q3 | $648K | Sell |
1,604
-27
| -2% | -$10.9K | 0.21% | 74 |
|
|
2018
Q2 | $572K | Buy |
1,631
+145
| +10% | +$50.9K | 0.21% | 76 |
|
|
2018
Q1 | $511K | Sell |
1,486
-46
| -3% | -$15.8K | 0.21% | 77 |
|
|
2017
Q4 | $575K | Buy |
1,532
+12
| +0.8% | +$4.5K | 0.25% | 79 |
|
|
2017
Q3 | $661K | Sell |
1,520
-120
| -7% | -$52.2K | 0.31% | 67 |
|
|
2017
Q2 | $833K | Sell |
1,640
-30
| -2% | -$15.2K | 0.41% | 54 |
|
|
2017
Q1 | $671K | Sell |
1,670
-65
| -4% | -$26.1K | 0.37% | 58 |
|
|
2016
Q4 | $597K | Sell |
1,735
-450
| -21% | -$155K | 0.4% | 54 |
|
|
2016
Q3 | $804K | Sell |
2,185
-105
| -5% | -$38.6K | 0.57% | 39 |
|
|
2016
Q2 | $823K | Sell |
2,290
-245
| -10% | -$88.1K | 0.64% | 38 |
|
|
2016
Q1 | $913K | Sell |
2,535
-310
| -11% | -$112K | 0.73% | 31 |
|
|
2015
Q4 | $1.54M | Buy |
2,845
+125
| +5% | +$67.8K | 1.11% | 23 |
|
|
2015
Q3 | $1.27M | Buy |
2,720
+25
| +0.9% | +$11.6K | 1.09% | 22 |
|
|
2015
Q2 | $1.37M | Buy |
2,695
+70
| +3% | +$35.7K | 1.15% | 17 |
|
|
2015
Q1 | $1.19M | Buy |
2,625
+285
| +12% | +$129K | 1.14% | 18 |
|
|
2014
Q4 | $959K | Buy |
+2,340
| New | +$959K | 1.12% | 16 |
|